摘要:
The present invention relates to a method for predicting the survival time of a patient suffering from a solid cancer comprising i) determining in a tissue sample obtained from the patient the gene expression level of FcRn ii) comparing expression level determined at step i) with their predetermined reference value and iii) providing a good prognosis when expression level determined at step i) is higher than their predetermined reference value, or providing a bad prognosis when expression levels determined at step i) are lower than their predetermined reference values.
摘要:
A multiple-axis hybrid manufacturing machine tool (1) for manufacturing a three-dimensional part, in particular a micro-part and/or a macro-part with a microfeature. The multiple-axis hybrid manufacturing machine tool (1) extends in a first direction (1001), a second direction (1002) and a third direction (1003) that are perpendicular to each other. The multiple-axis hybrid manufacturing machine tool (1) comprises a vat photopolymerization three-dimensional printing module (100), a container module (200), a CNC processing module (300) and a platform module (400). The vat photopolymerization three-dimensional printing module (100) comprises a movable illumination device (101). The container module (200) comprises at least one photopolymer receiving container (201) for receiving a photopolymer material in liquid phase. The CNC processing module (300) comprises a movable spindle (301) for holding a milling tool (10) and/or a measuring tool. The platform module (400) comprises a movable build platform (401) that is arranged and configured for vat photopolymerization three-dimensional printing of a work piece and/or on a work piece, and preferably also for CNC processing of a work piece, on the build platform (401).
摘要:
Novel inhibitors of the enzyme autotaxin are described. The inhibitors contain one or two zinc-binding groups at the appropriate distance, Also described are uses thereof, such as for the inhibition of autotaxin activity and the treatment of various conditions (e.g., inflammatory conditions, cancer, obesity, autoimmune diseases).
摘要:
Suggested is a new process for the selective hydrogenation of (poly)unsaturated hydrocarbons, in particular polyunsaturated fatty acid alkyl esters into the respective saturated and/or monounsaturated species, of aldehydes into respective alcohols and of aromatic compounds into respective saturated cyclic compounds using homogenous catalysts in a biphasic aqueous/organic solvent system, which is characterised in that said catalysts represent complexes of main-group I-V metals with water-soluble amine ligands.
摘要:
Organocatalysts that comprise a pyrrolidine ring and a thiodydantoin or a thioxopyrimidinone ring. The compounds are effective as catalysts in enantioselective and stereoselective organic reactions.
摘要:
A method for the quantification of SARS-CoV-2 in a sample comprising a one-step multiplex reverse transcription digital PCR assay. The method includes the simultaneous amplification of three transcripts of the N gene of SARS-CoV-2, an external control and an internal control.
摘要:
The invention discloses novel 4-hydroxycyclopent-2-en-1-one derivatives as active compounds in pharmaceutical compositions for the treatment of cancer. The invention confers cytotoxic effects of the said compounds on ovarian, colorectal, cervical, hepatocellular, lung, bladder and breast carcinomas, melanoma, lymphoma and myeloma malignant cells, for the inhibition of cell cycle progression at the G2/M phase, for reducing the expression of DNA replication licensing factors and for having general cancer treatment effects. It further discloses the use of the said compositions for the treatment of platinum-resistant tumors. Another aspect of the invention is the synergetic effects of these compounds with existing cancer treatment medicaments as the proteasomal inhibitors. Finally, the synthetic methods of the active compounds of the said compositions are disclosed.
摘要:
The present invention refers to the use of an encapsulated phase change material (31) in particulated form in a thermal energy storage tank of a solar heating unit (1) for heating water. Specifically, the solar heating unit can be used for heating domestic water.